+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Antihypertensive"

Resistant Hypertension Pipeline Analysis Report 2025 - Product Thumbnail Image

Resistant Hypertension Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Hypertension Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Hypertension Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Acute Ischemic Stroke Therapeutics Market 2026-2030 - Product Thumbnail Image

Acute Ischemic Stroke Therapeutics Market 2026-2030

  • Report
  • January 2026
  • 291 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Antihypertensives: Global Markets to 2023 - Product Thumbnail Image

Antihypertensives: Global Markets to 2023

  • Report
  • January 2019
  • 144 Pages
  • Global
From
From
Losartan Global Market Report 2025 - Product Thumbnail Image

Losartan Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Loading Indicator

The Antihypertensive market is a subset of the Cardiovascular Drugs market, which focuses on medications used to treat high blood pressure. These drugs are used to reduce the risk of stroke, heart attack, and other cardiovascular diseases. Antihypertensives work by blocking the action of certain hormones, such as angiotensin II, which cause blood vessels to constrict. Common classes of antihypertensives include diuretics, beta blockers, ACE inhibitors, calcium channel blockers, and angiotensin receptor blockers. The Antihypertensive market is highly competitive, with many large pharmaceutical companies offering a variety of products. Some of the major players in the market include Pfizer, Novartis, Merck, Sanofi, and GlaxoSmithKline. Other companies, such as AstraZeneca, Boehringer Ingelheim, and Daiichi Sankyo, also offer antihypertensive medications. Show Less Read more